Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19. Chong VH, Chong PL, Metussin D, Asli R, et al. J Med Virol 2020 May 13. doi: 10.1002/jmv.26004.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Chong VH, Chong PL, Metussin D, Asli R, et al. Conduction abnormalities in hydroxychloroquine add on therapy to lopinavir/ritonavir in COVID-19. J Med Virol 2020 May 13. doi: 10.1002/jmv.26004.
PMID: 32401368